Page last updated: 2024-09-05

cilengitide and Scleroderma, Systemic

cilengitide has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altavilla, D; Bagnato, G; Bagnato, GL; Bitto, A; Irrera, N; Pallio, G; Pizzino, G; Roberts, WN; Saitta, A; Santoro, D; Squadrito, F; Vaccaro, M	1

Other Studies

1 other study(ies) available for cilengitide and Scleroderma, Systemic

Article	Year
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis. Clinical science (London, England : 1979), 2018, 01-31, Volume: 132, Issue:2 Topics: Animals; Arteries; Disease Models, Animal; Female; Fibrosis; Gene Expression; Humans; Integrin alphaVbeta3; Mice, Inbred BALB C; Pulmonary Fibrosis; Receptors, Vitronectin; Scleroderma, Systemic; Skin; Snake Venoms; Transforming Growth Factor beta1	2018

Article

Year

Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis.

Clinical science (London, England : 1979), 2018, 01-31, Volume: 132, Issue:2

Topics: Animals; Arteries; Disease Models, Animal; Female; Fibrosis; Gene Expression; Humans; Integrin alphaVbeta3; Mice, Inbred BALB C; Pulmonary Fibrosis; Receptors, Vitronectin; Scleroderma, Systemic; Skin; Snake Venoms; Transforming Growth Factor beta1

2018